TP53 and cancer: Importantly, five pathways (PI3K/Akt, mTOR, FoxO, mitogen-activated protein kinase [MAPK], and p53) that were positively associated with m6A modification in GI cancer, overlapped with KEGG cancer pathways (Figure 3D).